Le Lézard
Classified in: Health
Subject: SVY

The global magnetic resonance imaging market is expected to reach US$ 7,955.1 Mn in 2025 from US$ 5,913.6 in 2017


NEW YORK, March 26, 2019 /PRNewswire/ -- The global magnetic resonance imaging market is expected to reach US$ 7,955.1 Mn in 2025 from US$ 5,913.6 in 2017. The magnetic resonance imaging market is estimated to grow with a CAGR of 3.8% from 2018-2025.

Read the full report: https://www.reportlinker.com/p05626751/?utm_source=PRN

In order to provide better access to health related services, the health ministry in various countries across the world are providing funds to the researchers as well as manufacturing companies to meet the increasing demand for diagnostic and treatment options.For instance, in February 2017, the Health Ministry in British Columbia announced an additional funding of US$ 25 Million to improve access to surgeries and MRI scans in the region.

However, the cost of the MRI systems are the major concern in the magnetic resonance imaging market.According to the Medicare Pricing Data 2015, the average price of an MRI scan in US costs up to US$ 2,611.

The reason behind high costs of MRI tests is the high cost of capital equipment as well as set up cost of the system incurred by private hospitals.Moreover, hybrid MRI systems refers to the process of complex minimally invasive imaging technique that combines two modalities to provide the information regarding the anatomy and physiology of human body.

The MRI can be combined with various other imaging techniques available in the market that includes computed tomography (CT), positron emission tomography (PET) or simple tools available for imaging such as X-ray fluoroscopy.

The architecture segment of the magnetic resonance imaging market is segmented into open MRI systems, and closed MRI systems.In 2017, the open MRI systems segment is anticipated to grow at the highest CAGR during the forecast period in the magnetic resonance imaging market.

The open architecture of the MRI scanners decreases the risk of claustrophobia and risk of panic attacks at exponential levels as well as allows patients of all the sizes and shapes to take up the MRI tests for accurate diagnosis and treatment of their medical conditions.

The application segment of the magnetic resonance imaging market is segmented into open cardiology, oncology, gastroenterology, musculoskeletal, neurology, and other applications.In 2017, the musculoskeletal segment is anticipated to grow at the highest CAGR during the forecast period in the magnetic resonance imaging market.

The advantages offered by the MRI such as increased signal-to-noise ratio, higher spatial resolution, improved spectral resolution for spectroscopy, improved sensitivity for X-nucleus imaging, and decreased image acquisition times.

Some of the major primary and secondary sources included in the report for the magnetic resonance imaging market are World Health Organization (WHO), American Cancer Society, National Cancer Institute, Health Ministry in British Columbia, Department of Health, Australian Government, Center for Devices and Radiological Health, Food and Drug Administration, Public Health England, and Health Protection Agency among others.

Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the magnetic resonance imaging market.
-Highlights key business priorities in order to assist companies to realign their business strategies.
-The key findings and recommendations highlight crucial progressive industry trends in the global magnetic resonance imaging market, thereby allowing players across the value chain to develop effective long-term strategies.
-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Read the full report: https://www.reportlinker.com/p05626751/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...



News published on and distributed by: